PTEN and kidney cancer: Another study indicated that the sensitivity of kidney cancer cells to sunitinib is mediated by the regulation of the expression of the oncogene PTEN, which may allow sunitinib to exert its inhibitory effect on kidney cancer cell activity at lower concentrations [27].